CCDC24 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-56417
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: IIKDQLNVSNIDQVARHLRGLLEEECHTLEREILILQRCLEEEYLRPCHPSEAALEPTLAELKEQKKAMEQEL
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for CCDC24 Antibody
Immunocytochemistry/ Immunofluorescence: CCDC24 Antibody [NBP2-56417]
Immunocytochemistry/Immunofluorescence: CCDC24 Antibody [NBP2-56417] - Staining of human cell line U-2 OS shows localization to plasma membrane & cytosol.Applications for CCDC24 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CCDC24
Alternate Names
Coiled-Coil Domain Containing 24, Coiled-Coil Domain-Containing Protein 24, RP5-1198O20.2
Gene Symbol
CCDC24
Additional CCDC24 Products
Product Documents for CCDC24 Antibody
Product Specific Notices for CCDC24 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...